Showing results (101-110 of 544) with videos related to
Sort By:
Pageof 55
European Cytokine Network|November 1, 1992
Tumor necrosis factor alpha production as a possible predictor of relapse in patients with multiple sclerosisM Chofflon, C Juillard, P Juillard, et al.American Journal of Public Health|December 2, 2006
Assessment of HIV testing of urban injection drug users: implications for expansion of HIV testing and prevention effortsRobert Heimer, Lauretta E Grau, Erin Curtin, et al.Clinical Immunology and Immunopathology|April 1, 1992
Serum tumor necrosis factor and interleukin 1 in leprosy and during lepra reactionsS K Parida, G E Grau, S A Zaheer, et al.BMC Public Health|August 10, 2014
Factors associated with hepatitis B vaccine series completion in a randomized trial for injection drug users reached through syringe exchange programs in three US citiesSarah Bowman, Lauretta E Grau, Merrill Singer, et al.Anales Espanoles De Pediatria|June 1, 1983
[Pharmacologic treatment of patent ductus arteriosus in premature infants]C Vázquez, A Cabrera, E Pastor, et al.Anales Espanoles De Pediatria|December 1, 1980
[Congenital pulmonary lymphangiectasis. Report of four cases (author's transl)]I Fidalgo, F Ortega, J Alustiza, et al.Plos Medicine|August 18, 2005
Inhibition of endothelial activation: a new way to treat cerebral malaria?Samuel C Wassmer, George J Cianciolo, Valéry Combes, et al.Drug and Alcohol Dependence|June 28, 2011
Prevalence, characteristics, and predictors of police training initiatives by US SEPs: building an evidence base for structural interventionsL Beletsky, L E Grau, E White, et al.Schweizerische Medizinische Wochenschrift|December 9, 1989
[Tumor necrosis factor (TNF) and pathology; its relationships with other cytokines]G E Grau, P H Lambert, P Vassalli, et al.Cytokine|January 1, 1993
Interleukin 1 receptor antagonist (IL-1ra) prevents or cures pulmonary fibrosis elicited in mice by bleomycin or silicaP F Piguet, C Vesin, G E Grau, et al.Pageof 55